Tiabendazole

Tiabendazole
Clinical data
Trade names	Mintezol, others
AHFS/Drugs.com	International Drug Names
Pregnancy; category	AU: B3;
Routes of; administration	By mouth, topical
ATC code	D01AC06 (WHO) P02CA02 (WHO) QP52AC10 (WHO);
Legal status
Legal status	AU: S4 (Prescription only); In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	Сmax 1–2 hours (oral administration)
Metabolism	GI tract
Elimination half-life	8 hours
Excretion	Urine (90%)
Identifiers
	IUPAC name 4-(1H-1,3-Benzodiazol-2-yl)-1,3-thiazole;
CAS Number	148-79-8 ;
PubChem CID	5430;
IUPHAR/BPS	7304;
DrugBank	DB00730 ;
ChemSpider	5237 ;
UNII	N1Q45E87DT;
KEGG	D00372 ;
ChEMBL	ChEMBL625 ;
NIAID ChemDB	007903;
CompTox Dashboard (EPA)	DTXSID0021337 ;
ECHA InfoCard	100.005.206
Chemical and physical data
Formula	C10H7N3S
Molar mass	201.25 g·mol−1
3D model (JSmol)	Interactive image;
Density	1.103 g/cm3
Melting point	293 to 305 °C (559 to 581 °F)
	SMILES [nH]1c2ccccc2nc1c3cscn3;
	InChI InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13) ; Key:WJCNZQLZVWNLKY-UHFFFAOYSA-N ;
	(what is this?) (verify)

Tiabendazole (INN, BAN), also known as thiabendazole (AAN, USAN) or TBZ and the trade names Mintezol, Tresaderm, and Arbotect, is a preservative, an antifungal agent, and an antiparasitic agent.